loadpatents
name:-0.024041175842285
name:-0.020231962203979
name:-0.0016560554504395
ZUR MEGEDE; Jan Patent Filings

ZUR MEGEDE; Jan

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZUR MEGEDE; Jan.The latest application filed is for "digital immunoassay".

Company Profile
1.18.21
  • ZUR MEGEDE; Jan - Hercules CA
  • Zur Megede; Jan - San Francisco CA
  • Zur Megede; Jan - Emeryville CA US
  • zur Megede; Jan - Larkspur CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Digital Immunoassay
App 20200408747 - ZUR MEGEDE; Jan ;   et al.
2020-12-31
Digital immunoassay
Grant 10,809,250 - zur Megede , et al. October 20, 2
2020-10-20
Digital polymerase fidelity assay
Grant 10,287,620 - Cheng , et al.
2019-05-14
Digital Immunoassay
App 20180238865 - Zur Megede; Jan ;   et al.
2018-08-23
Digital Polymerase Fidelity Assay
App 20170314060 - CHENG; Man ;   et al.
2017-11-02
HIV-1 south african subtype C env proteins
Grant 9,598,469 - Zur Megede , et al. March 21, 2
2017-03-21
Hiv-1 South African Subtype C Env Proteins
App 20140220060 - ZUR MEGEDE; Jan ;   et al.
2014-08-07
Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes
Grant 8,637,044 - Barnett , et al. January 28, 2
2014-01-28
Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
Grant 8,541,230 - Barnett , et al. September 24, 2
2013-09-24
Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV
Grant 8,518,694 - Hardy , et al. August 27, 2
2013-08-27
Expression Cassettes Endcoding Hiv-1 South African Subtype C Modified Proteins
App 20120269851 - zur Megede; Jan ;   et al.
2012-10-25
Expression Of Hiv Polypeptides And Production Of Virus-like Particles
App 20120269840 - BARNETT; Susan W. ;   et al.
2012-10-25
Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof
Grant 8,263,394 - zur Megede , et al. September 11, 2
2012-09-11
Hiv Tat-cd4 Hybrid Molecules And Methods Of Use Thereof
App 20120183557 - BARNETT; Susan ;   et al.
2012-07-19
Expression of HIV polypeptides and production of virus-like particles
Grant 8,168,418 - Barnett , et al. May 1, 2
2012-05-01
Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2
Grant 8,133,494 - zur Megede , et al. March 13, 2
2012-03-13
Polynucleotides Encoding Antigenic Hiv Type C Polypeptides, Polypeptides And Uses Thereof
App 20110236469 - BARNETT; Susan W. ;   et al.
2011-09-29
Polynucleotides Encoding Antigenic Hiv Type C Polypeptides, Polypeptides And Uses Thereof
App 20110212164 - BARNETT; Susan ;   et al.
2011-09-01
Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
Grant 7,943,375 - Barnett , et al. May 17, 2
2011-05-17
Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
Grant 7,935,805 - Barnett , et al. May 3, 2
2011-05-03
Hiv Polynucleotides And Polypeptides Derived From Botswana Mj4
App 20110052632 - LIAN; YING ;   et al.
2011-03-03
Hiv Vaccine For Mucosal Delivery
App 20110045017 - LIAN; YING ;   et al.
2011-02-24
Expression of HIV polypeptides and production of virus-like particles
Grant 7,718,401 - Barnett , et al. May 18, 2
2010-05-18
Vectors for expression of hml-2 polypeptides
App 20100086565 - Hardy; Stephen F. ;   et al.
2010-04-08
Polycistronic Hiv Vector Constructs
App 20100040676 - zur Megede; Jan ;   et al.
2010-02-18
Polycistronic HIV vector constructs
Grant 7,622,125 - zur Megede , et al. November 24, 2
2009-11-24
Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins
Grant 7,618,642 - zur Megede , et al. November 17, 2
2009-11-17
HIV polynucleotides and polypeptides derived from Botswana MJ4
App 20090208530 - Lian; Ying ;   et al.
2009-08-20
Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
App 20090047339 - Barnett; Susan W. ;   et al.
2009-02-19
Polynucleotides Encoding Antigenic Hiv Type B Polypeptides, Polypeptides, And Uses Thereof
App 20090004733 - zur Megede; Jan ;   et al.
2009-01-01
Expression Of Hiv Polypeptides And Production Of Virus-like Particles
App 20080261271 - Barnett; Susan W. ;   et al.
2008-10-23
Polynucleotides Encoding Antigenic Hiv Type B Polypeptides, Polypeptides, And Uses Thereof
App 20080095833 - Zur Megede; Jan ;   et al.
2008-04-24
Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
Grant 7,211,659 - zur Megede , et al. May 1, 2
2007-05-01
Hiv polynucleotides and polypeptides derived from botswana mj4
App 20070073048 - Lian; Ying ;   et al.
2007-03-29
Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
App 20060057115 - zur Megede; Jan ;   et al.
2006-03-16
Polycistronic HIV vector constructs
App 20050287167 - zur Megede, Jan ;   et al.
2005-12-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed